Submitting OIG:
Report Description:
This report fulfills for 2017 the annual reporting mandate from the Patient Protection and Affordable Care Act (ACA) for 2017. The ACA requires OIG to conduct a study of the extent to which formularies used by Medicare Part D plans include drugs commonly used by full benefit dual eligible individuals (i.e., individuals who are eligible for both Medicare and full Medicaid benefits). These individuals generally get drug coverage through Medicare Part D. Pursuant to the ACA, OIG must annually issue a report with recommendations as appropriate. This is the seventh report the OIG has produced to meet this mandate.
Date Issued:
Friday, June 30, 2017
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
OEI-05-17-00160
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Inspection / Evaluation
Questioned Costs:
$0
Funds for Better Use:
$0
Number of Recommendations:
0
View Document:
Attachment | Size |
---|---|
oei-05-17-00160.pdf | 1.22 MB |
Additional Details Link: